ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $238,740 | -25.7% | 8,885 | -1.4% | 0.01% | -27.3% |
Q2 2023 | $321,297 | +33.3% | 9,010 | -5.0% | 0.01% | +10.0% |
Q1 2023 | $240,995 | -37.4% | 9,488 | 0.0% | 0.01% | -47.4% |
Q4 2022 | $384,833 | -99.9% | 9,488 | +1.5% | 0.02% | +26.7% |
Q3 2022 | $309,018,000 | +108327.4% | 9,350 | +15.5% | 0.02% | +15.4% |
Q2 2022 | $285,000 | -24.4% | 8,093 | -1.3% | 0.01% | -7.1% |
Q1 2022 | $377,000 | -23.1% | 8,203 | +10.9% | 0.01% | -17.6% |
Q4 2021 | $490,000 | +21.9% | 7,395 | +14.8% | 0.02% | +13.3% |
Q3 2021 | $402,000 | -11.1% | 6,443 | +18.1% | 0.02% | -6.2% |
Q2 2021 | $452,000 | +44.9% | 5,456 | +16.0% | 0.02% | +23.1% |
Q1 2021 | $312,000 | – | 4,703 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |